Monopar Therapeutics

US Markets

Monopar (NASDAQ: MNPR) Stock Skyrockets on Upbeat MNPR-101 Radiopharmaceutical Program Findings

Edward Cooke / 23 February 2024

Monopar Therapeutics (NASDAQ: MNPR) stock soared after reporting promising preclinical results for the MNPR-101 radiopharmaceutical program. On Thursday, Monopar Therapeutics […]

Monopar (NASDAQ: MNPR) Stock Skyrockets on Upbeat MNPR-101 Radiopharmaceutical Program Findings Read More »

US Markets

Monopar Therapeutics (NASDAQ: MNPR) Stock Surges on HREC Clearance for MNPR-101-Zr Trial

Edward Cooke / 21 February 2024

Monopar Therapeutics (NASDAQ: MNPR) stock skyrocketed on news of HREC clearance in Australia for the Phase 1 dosimetry trial of

Monopar Therapeutics (NASDAQ: MNPR) Stock Surges on HREC Clearance for MNPR-101-Zr Trial Read More »

Monopar (NASDAQ: MNPR) Stock Skyrockets on Upbeat MNPR-101 Radiopharmaceutical Program Findings

Monopar Therapeutics (NASDAQ: MNPR) Stock Surges on HREC Clearance for MNPR-101-Zr Trial

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer